Physician

Jeff Porter Sharman, M.D.

According to 2025 Medicare claims, Jeff Sharman, M.D. (NPI: 1659596179) practices hematology/oncology in the Eugene-Springfield, OR market, with the plurality of this provider's patient population coming from Lane, OR. This provider's primary affiliated billing organization is ONCOLOGY ASSOCIATES OF OREGON P C (NPI: 1013989854; TIN: 930746296) and primary practice location at 97401-6036. Sharman is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Sharman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 712 traditional Medicare patients, billed 147,195 HCPCS/CPT codes, and received $2,840,385 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,567 prescription claims across 288 beneficiaries totaling $9,523,116 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 11 claims. Open Payments data shows 665 records totaling $2,306,789. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,928,989 to $9,523,116. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2015 Medicare payment: $1,898,248 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,176,530 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,310,487 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,654,662 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,596,471 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,237,942 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,887,246 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,686,998 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,748,787 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,840,385 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015439121,654$1,898,248
2016514148,751$2,176,530
2017572153,665$2,310,487
2018597110,204$1,654,662
2019596105,021$1,596,471
2020600151,344$2,237,942
2021631124,140$1,887,246
2022561106,802$1,686,998
202356998,508$1,748,787
2024712147,195$2,840,385

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.0M$10M2015 Drug cost: $2,928,989 (USD; Tot_Drug_Cst)2016 Drug cost: $3,695,404 (USD; Tot_Drug_Cst)2017 Drug cost: $4,414,682 (USD; Tot_Drug_Cst)2018 Drug cost: $5,209,345 (USD; Tot_Drug_Cst)2019 Drug cost: $7,565,039 (USD; Tot_Drug_Cst)2020 Drug cost: $8,603,126 (USD; Tot_Drug_Cst)2021 Drug cost: $10,088,046 (USD; Tot_Drug_Cst)2022 Drug cost: $7,966,027 (USD; Tot_Drug_Cst)2023 Drug cost: $5,804,772 (USD; Tot_Drug_Cst)2024 Drug cost: $9,523,116 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151901,321$2,928,989
20162151,370$3,695,404
20172281,437$4,414,682
20182311,539$5,209,345
20192391,771$7,565,039
20202361,676$8,603,126
20212421,795$10,088,046
20222391,455$7,966,027
20232251,228$5,804,772
20242881,567$9,523,116

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$19K$37K2015 Medicare payment: $37,346 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $15,631 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $4,840 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $504 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $556 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R91$37,346
2016N/R63$15,631
2017N/RN/RN/R
2018N/R28$4,840
2019N/R12$504
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R11$556

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more302518$66
80053Blood test, comprehensive group of blood chemicals4471,244$10
36415Insertion of needle into vein for collection of blood sample4511,274$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4481,272$8
83615Lactate dehydrogenase (enzyme) level323876$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BrukinsaZanubrutinib1554,650$2,125,897
CalquenceAcalabrutinib Maleate1303,885$1,870,371
LenalidomideLenalidomide661,848$843,879
RevlimidLenalidomide381,064$628,720
ImbruvicaIbrutinib35996$554,891

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0656Segmental pneumatic appliance for use with pneumatic compressor, trunkYN/R11$556

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.29$24,636Eli Lilly and Company
Research PaymentsReported research-related payment or transfer-of-value amount.636$2,282,154BeiGene, Ltd.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jeff Porter Sharman, M.D.?

Tedicare shows public-source Medicare data for Jeff Porter Sharman, M.D. (NPI 1659596179), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeff Porter Sharman, M.D. have ACO affiliation data?

Jeff Porter Sharman, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Jeff Porter Sharman, M.D.?

Jeff Porter Sharman, M.D. is linked to ONCOLOGY ASSOCIATES OF OREGON P C (billing NPI 1013989854) in the available physician profile data.

Does Jeff Porter Sharman, M.D. have Open Payments data?

Jeff Porter Sharman, M.D. has 665 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.